LI
LMCG Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
33,597
+19,116
| +132% | +$10M | 1.11% | 22 |
|
|
2025
Q1 | $9.18M | Buy |
14,481
+10,110
| +231% | +$6.41M | 0.61% | 55 |
|
|
2024
Q4 | $3.11M | Sell |
4,371
-453
| -9% | -$323K | 0.19% | 121 |
|
|
2024
Q3 | $5.07M | Sell |
4,824
-8
| -0.2% | -$8.41K | 0.3% | 96 |
|
|
2024
Q2 | $5.08M | Buy |
4,832
+215
| +5% | +$226K | 0.3% | 100 |
|
|
2024
Q1 | $4.44M | Sell |
4,617
-15
| -0.3% | -$14.4K | 0.26% | 108 |
|
|
2023
Q4 | $4.07M | Sell |
4,632
-14
| -0.3% | -$12.3K | 0.25% | 109 |
|
|
2023
Q3 | $3.82M | Sell |
4,646
-110
| -2% | -$90.5K | 0.26% | 110 |
|
|
2023
Q2 | $3.42M | Sell |
4,756
-129
| -3% | -$92.7K | 0.22% | 115 |
|
|
2023
Q1 | $4.01M | Buy |
4,885
+70
| +1% | +$57.5K | 0.27% | 104 |
|
|
2022
Q4 | $3.47M | Buy |
4,815
+59
| +1% | +$42.6K | 0.24% | 112 |
|
|
2022
Q3 | $3.28M | Buy |
4,756
+48
| +1% | +$33.1K | 0.24% | 117 |
|
|
2022
Q2 | $2.78M | Buy |
4,708
+78
| +2% | +$46.1K | 0.19% | 131 |
|
|
2022
Q1 | $3.23M | Buy |
+4,630
| New | +$3.23M | 0.19% | 134 |
|